Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers

NCT05847218 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability
Pharmacokinetics

Interventions

DRUG: RHN-001 (one tablet 750mg)
DRUG: RHN-001 (750mg * 2 Tablets)

Sponsor

RH Nanopharmaceuticals

Collaborators

[object Object]